Organon And Co
Clinical trials sponsored by Organon And Co, explained in plain language.
-
Two drugs better than one? study tests cholesterol combo for High-Risk hearts
Disease control CompletedThis study tested if adding a second cholesterol drug, ezetimibe, to a common statin (atorvastatin) works better than the statin alone for very high-risk heart disease patients. It involved 137 adults with existing heart or blood vessel disease who needed better cholesterol contr…
Phase: PHASE4 • Sponsor: Organon and Co • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New cream shows promise for controlling severe eczema flares
Disease control CompletedThis study tested a new topical cream called tapinarof for people with moderate to severe eczema (atopic dermatitis). Over 400 children and adults applied the cream or a placebo once daily for 8 weeks to see if it could clear or nearly clear their skin and reduce itching. The goa…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New eczema cream tested for safety in kids
Disease control CompletedThis study tested the safety and how much of a new topical cream called tapinarof gets into the body when used by children with widespread atopic dermatitis (eczema). 36 children aged 2 to 17 applied the cream daily for 4 weeks. The main goal was to check for side effects and mea…
Phase: PHASE2 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New cream shows promise for clearing stubborn eczema
Disease control CompletedThis study tested a once-daily cream called tapinarof for people with moderate to severe eczema. Over 400 children and adults used the cream or a placebo for 8 weeks to see if it could clear or nearly clear their skin. The main goal was to see if the active cream was more effecti…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Birth control implant tested for two extra years of protection
Prevention CompletedThis study tested whether a birth control implant remains effective and safe for two years longer than its current approval. It involved nearly 500 women aged 35 or younger who had already used the implant for three years. The goal was to see if the implant could reliably prevent…
Phase: PHASE3 • Sponsor: Organon and Co • Aim: Prevention
Last updated Mar 30, 2026 14:31 UTC